Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003540065 | SCV004284627 | uncertain significance | Emery-Dreifuss muscular dystrophy | 2023-05-16 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with SUN2-related conditions. This variant is present in population databases (rs149626068, gnomAD 0.005%). This sequence change replaces serine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 151 of the SUN2 protein (p.Ser151Cys). |
Ambry Genetics | RCV004867883 | SCV005511368 | uncertain significance | not specified | 2024-08-07 | criteria provided, single submitter | clinical testing | The c.452C>G (p.S151C) alteration is located in exon 5 (coding exon 4) of the SUN2 gene. This alteration results from a C to G substitution at nucleotide position 452, causing the serine (S) at amino acid position 151 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |